Position in ARDX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,873,143
+$22,645 QoQ
Shares Held
312,712
-1.5% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. ARDX ranks #126 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in ARDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,873,143 | 312,712 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,850,498 | 317,410 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,420,547 | 257,813 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $900,328 | 229,676 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $871,666 | 177,529 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $633,469 | 124,945 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $788,428 | 114,431 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $834,142 | 112,570 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $841,652 | 115,295 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $14,465,386 | 2,333,127 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,560,953 | 1,362,979 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $400,850 | 118,245 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,423,735 | 1,132,304 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $48,937 | 17,171 | Shares | Defined | 2023-02-13 | |
| 2022-03-31 | $31,995 | 29,902 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $33,207 | 30,189 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $51,195 | 38,785 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $246,213 | 32,482 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $111,076 | 16,779 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $85,422 | 13,203 | Shares | Defined | 2021-02-16 | |
| 2020-03-31 | $622,393 | 109,480 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||